Back to Top Skip to main content

Human Papillomavirus

Human papillomavirus

Human papillomavirus (HPV) is a group of more than 150 related viruses. Each virus in this large group is given a number, which is called its HPV type. HPV is named for the warts (papillomas) some HPV types can cause. Some other HPV types can lead to cancer of the mouth/throat and anus/rectum, in both men and women. Men can also get penile HPV cancer. In women, HPV infection can also cause cervical, vaginal, and vulvar HPV cancers.

HPV is transmitted through intimate skin-to-skin contact. You can get HPV by having vaginal, anal, or oral sex with someone who has the virus. It is most commonly spread during vaginal or anal sex. HPV is so common that nearly all men and women get it at some point in their lives. HPV can be passed even when an infected person has no signs or symptoms. You can develop symptoms years after being infected, making it hard to know when you first became infected.

In most cases, HPV goes away on its own and does not cause any health problems. But when HPV does not go away, it can cause health problems like genital warts and cancer.

Genital warts usually appear as a small bump or groups of bumps in the genital area. They can be small or large, raised or flat, or shaped like a cauliflower. A healthcare provider can usually diagnose warts by looking at the genital area.

HPV cancers include cancer of the cervix, vulva, vagina, penis, or anus. HPV infection can also cause cancer in the back of the throat, including the base of the tongue and tonsils.

HPV vaccine is important because it protects against cancer. Every year in the United States, HPV causes more than 30,000 cancers in men and women. HPV vaccination can prevent most of the cancers (about 90 percent) from occurring.  All kids who are 9 through 14 years old should receive two doses of HPV vaccine 6 to 12 months apart. Adolescents who receive their two doses less than five months apart will require a third dose of HPV vaccine. Anyone who is 15 through 26 years old receiving the vaccine for the first time should receive three doses of the HPV vaccine. The second dose of the vaccine should be received two months after the first dose, and the third dose should be received six months after the initial dose. Also, three doses are still recommended for people with certain immunocompromising conditions aged 9 through 26 years.  Teen boys and girls who did not start or finish the HPV vaccine series when they were younger should get it now.

HPV vaccine is recommended for females through age 26, and males through age 21. HPV vaccine is also recommended for the following people, if they did not get vaccinated when they were younger:

  • young men who have sex with men, including young men who identify as gay or bisexual or who intend to have sex with men through age 26;
  • young adults who are transgender through age 26; and
  • young adults with certain immunocompromising conditions (including HIV) through age 26.

Source: Centers for Disease Control and Prevention


You also may be interested in...

Human Papilloma Virus (HPV) and HPV Vaccines

Fact Sheet
8/16/2017

This information paper describes Human Papilloma Virus and the vaccine to prevent it.

Recommended Content:

Human Papillomavirus

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination

Report
12/16/2016

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices

Recommended Content:

Human Papillomavirus | Vaccine Schedules

The HPV Vaccine Saves Lives

Infographic
5/16/2016
The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). This graphic highlights information the benefits of the HPV vaccine. The vaccine is most effective among fully vaccinated individuals.   Cancer Prevention Facts •	HPV is the most common sexually  transmitted infection (STI) •	There are more than 40 HPV types that can infect the genital areas •	Some HPV types give warts •	Some HPV types develop cancer  Effective Against STI Transmission •	The HPV vaccine is a safe and effective way to protect yourself from the virus •	The HPV vaccine provides nearly 100% protection from HPV types 6,11,16 and 18 •	HPV vaccine shows early signs of success in reducing HPV infections and related illnesses •	Protection is expected to be long-lasting  Safety Tips •	Getting your HPV vaccine and practicing safe sex such as wearing a condom may lower the risk of HPV •	Limiting the number of lifetime sex partners can also lower the risk of HPV •	When given the HPV vaccine, the body makes antibodies in response to the protection to clear it from the body  Get the Facts •	2,091 female service members aged 17-26 years received 1-3 HPV4 doses during 2006-2012, stratified by number of doses (1, 2, or 3).  Get the HPV Vaccine •	Only 22.5% of eligible service members initiated the series •	Of those, only 39.1% completed the full three-dose series as of June 2011.  Even though the 3 dose regiment provides nearly complete protection against HPV16 and HPV18, in the U.S., only 12% and 19% of female adolescents among commercial and Medicaid plans respectively complete the series.  Read HPV Facts from the CDC: https://www.ok.gov/health2/documents/IMM_Teens_HPV_Facts.pdf  Read the STI issue of the Medical Surveillance Monthly Report at Health.Mil/MSMR   Get the conversation started. Ask your healthcare provider about the HPV vaccine today. Follow us on Twitter @AFHSBPAGE and use hashtag #VaccinesWork.

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4).

Recommended Content:

Preventive Health | Immunizations | Men's Health | Human Papillomavirus | Armed Forces Health Surveillance Branch | Women's Health

HPV (Gardasil) Vaccine Information Statement

Publication
5/17/2013

Gardasil Vaccine Information Statement

Recommended Content:

Human Papillomavirus

Recommendations for the Use of Quadrivalent HPV Vaccines in the Navy and Marine Corps

Policy
  • Identification #: BUMED NOTICE 6230
  • Date: 12/10/2012
  • Type: Directives
  • Topics: Human Papillomavirus

COGARD Human Papillomavirus Vaccine for Males

Policy

Human Papillomavirus Vaccination Policy

Policy

Air Force Human Papillomavirus Vaccination Policy

ALCOAST Gardasil Human Papillomavirus Vaccine

Policy
<< < 1 > >> 
Showing results 1 - 8 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.